Open AccessRandomized, placebo controlled phase I trial of the safety, pharmacokinetics, pharmacodynamics and acceptability of a 90 day tenofovir plus levonorgestrel vaginal ring used continuously or cyclically in women: The CONRAD 138 study
Author(s) -
Andrea Ries Thurman,
Vivian Brache,
Leila Cochón,
Louise A. Ouattara,
Neelima Chandra,
Terry A. Jacot,
Nazita Yousefieh,
Meredith R. Clark,
M. Melissa Peet,
Homaira Hanif,
Jill L. Schwartz,
Susan Ju,
Mark A. Marzinke,
David W. Erikson,
Urvi M. Parikh,
Betsy C. Herold,
Rai. Fichorova,
Elizabeth E. Tolley,
Gustavo F. Doncel
Publication year - 2022
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0275794
Subject(s) - levonorgestrel , placebo , pharmacodynamics , medicine , adverse effect , tolerability , pharmacokinetics , randomized controlled trial , pharmacology , physiology , population , family planning , alternative medicine , environmental health , pathology , research methodology